Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.177.15ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.24ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.236ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.153ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.302ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.194ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.55ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.51ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.308ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.138ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.379ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.240ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.240.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.46ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.44ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CP.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.39ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.40ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.3.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BM.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.57ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EF.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.29ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.32ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BW.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CK.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CM.8.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CA.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.61ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
ED.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BU.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.3.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XCGENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.30ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DT.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DT.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XCAENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.50ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.54ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GN.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.77 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBLENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EK.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.466.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.36ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.222ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used